Nuveen (JQC) Suspends Trading of Rights, Moves to OTC Market

Author's Avatar
Apr 15, 2025
Article's Main Image
  • Nuveen Credit Strategies Income Fund will cease trading its subscription rights on the NYSE.
  • Rights identified as JQCNR fall below the $0.01 pricing threshold.
  • These rights will move to the OTC Market, contingent on market conditions.

Trading Halt for Nuveen Credit Strategies Income Fund

Nuveen Credit Strategies Income Fund (JQC) has announced a significant change regarding its transferrable subscription rights. On April 7, 2025, these rights will no longer be traded on the New York Stock Exchange (NYSE) due to their pricing dropping below $0.01. This key decision could impact the fund's market presence and investor opportunities.

Transition to OTC Market

Known by the ticker JQCNR, the rights will make a shift to the OTC Market if market dynamics allow for such a transition. This move aims to provide a venue for trading despite the current pricing challenges. The transition is contingent upon any developments in market conditions, ensuring the fund retains its accessibility to potential investors.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.